Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.06
Bid: 52.06
Ask: 52.10
Change: -0.14 (-0.27%)
Spread: 0.04 (0.077%)
Open: 52.00
High: 52.74
Low: 52.00
Prev. Close: 52.20
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UKFI Announce Trading Plan in Lloyds Banking Group

7 Oct 2016 13:35

RNS Number : 0221M
UK Financial Investments Limited
07 October 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

 

 

7th October 2016

 

 

UK Financial Investments Limited ("UKFI")

 

Intention to sell shares in Lloyds Banking Group plc through a trading plan

 

 

UKFI today announces that it intends to continue to sell Her Majesty's Treasury's ("HMT") shareholding in Lloyds Banking Group plc (the "Company") over the next twelve months through a pre-arranged trading plan that will be managed by Morgan Stanley & Co. International plc ("Morgan Stanley").

 

Under the trading plan, Morgan Stanley will have full discretion to effect a measured and orderly sell down of shares in the Company on behalf of HMT.

 

The trading plan will commence today and will terminate no later than 6 October 2017. HMT has instructed Morgan Stanley that (a) up to, but no more than, 15% of the aggregate total trading volume in the Company may be sold over the duration of the trading plan, and (b) shares may not be sold under the trading plan below a certain price per share that UKFI and HMT have determined represents fair value currently and continues to deliver value for money for the taxpayer.

HMT currently owns approximately 6.5 billion ordinary shares in the Company, which represents approximately 9.1% of the issued ordinary share capital of the Company.

 

Goldman Sachs International is acting as Privatisation Strategy Adviser to UKFI.

 

Freshfields Bruckhaus Deringer LLP is acting as Legal Counsel to UKFI in respect of English and US law.

 

 

Contact:

 

Maitland Consultancy: Daniel Yea +44 (0) 20 7379 5151; +44 (0) 7595 270 691

 

 

 

Important notice

This press release is for information purposes only and does not constitute or form a part of an offer to sell or a solicitation of an offer to purchase any security of the Company in the United States or in any other jurisdiction where such offer or solicitation is unlawful. The securities of the Company described in this press release have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or any applicable state or foreign securities laws and may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act. There shall be no public offering of securities in the United States or any other jurisdiction.

Goldman Sachs International and Morgan Stanley & Co. International plc (together, the "Banks"), which are authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, are acting on behalf of HM Treasury and UKFI and no one else in connection with the trading plan and will not be responsible to any other person for providing the protections afforded to any of their respective clients or for providing advice to any other person in relation to the trading plan. Neither of the Banks will regard any other person as its client in relation to the trading plan. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by either of the Banks or by any of their respective affiliates or agents as to or in relation to, the accuracy, completeness or sufficiency of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers in connection with HMT, UKFI, the Company, the trading plan or any of the arrangements described herein, and any liability therefore is expressly disclaimed.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAAEXEAKKFFF
Date   Source Headline
23rd Mar 20235:33 pmRNSTransaction in Own Shares
23rd Mar 20232:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:27 pmRNSTransaction in Own Shares
22nd Mar 202311:25 amRNS2022 Annual Report and Accounts
21st Mar 20235:55 pmRNSNotice of AGM
21st Mar 20235:40 pmRNSTransaction in Own Shares
20th Mar 20235:26 pmRNSTransaction in Own Shares
17th Mar 20235:28 pmRNSTransaction in Own Shares
16th Mar 20235:47 pmRNSTransaction in Own Shares
15th Mar 20235:33 pmRNSTransaction in Own Shares
14th Mar 20235:20 pmRNSTransaction in Own Shares
13th Mar 20235:29 pmRNSTransaction in Own Shares
10th Mar 20235:58 pmRNSTransaction in Own Shares
10th Mar 20234:07 pmRNSDirector/PDMR Shareholding
9th Mar 20235:43 pmRNSTransaction in Own Shares
8th Mar 20236:06 pmRNSTransaction in Own Shares
8th Mar 20232:26 pmRNSDirector/PDMR Shareholding
7th Mar 20235:39 pmRNSTransaction in Own Shares
7th Mar 20233:08 pmRNS2022 Form 20F Filed
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
7th Mar 202310:37 amRNS2022 Annual Report and Accounts
6th Mar 20235:52 pmRNSTransaction in Own Shares
3rd Mar 20235:41 pmRNSTransaction in Own Shares
2nd Mar 20235:37 pmRNSTransaction in Own Shares
2nd Mar 202312:04 pmRNSPublication of Final Terms
1st Mar 20235:26 pmRNSTransaction in Own Shares
28th Feb 20235:41 pmRNSTransaction in Own Shares
28th Feb 20233:37 pmRNSTotal Voting Rights
27th Feb 20235:26 pmRNSTransaction in Own Shares
27th Feb 20232:00 pmRNSDirector/PDMR Shareholding
24th Feb 20235:46 pmRNSTransaction in Own Shares
24th Feb 20235:03 pmRNS2022 Form 20F Filed
23rd Feb 20236:07 pmRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSShare Buyback Programme Commences
22nd Feb 202311:38 amRNSPublication of Suppl.Prospcts
22nd Feb 20237:00 amRNS2022 Annual Report and Accounts
22nd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20235:00 pmRNSDirector/PDMR Shareholding
31st Jan 20234:57 pmRNSTotal Voting Rights
11th Jan 20232:36 pmRNSPublication of Final Terms
11th Jan 20232:15 pmRNSDirector/PDMR Shareholding
3rd Jan 202310:00 amRNSBlock listing Interim Review
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20224:36 pmRNSDirector/PDMR Shareholding
12th Dec 20224:09 pmRNSDirector/PDMR Shareholding
7th Dec 20222:00 pmRNSBlock Listing of Shares
1st Dec 20229:57 amRNSDirector/PDMR Shareholding
30th Nov 20223:31 pmRNSTotal Voting Rights
16th Nov 20224:30 pmRNSDirector/PDMR Shareholding
10th Nov 20223:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.